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A New Paramagnetically Shifted Imaging Probe for MRI
P. Kanthi Senanayake,1 Nicola J. Rogers,1 Katie-Louise N.A. Finney,1 Peter Harvey,1
Alexander M. Funk,1 J. Ian Wilson,2 Dara O’Hogain,3 Ross Maxwell,2 David Parker,1
and Andrew M. Blamire3*
Purpose: To develop and characterize a new paramagnetic
contrast agent for molecular imaging by MRI.
Methods: A contrast agent was developed for direct MRI
detection through the paramagnetically shifted proton mag-
netic resonances of two chemically equivalent tert-butyl
reporter groups within a dysprosium(III) complex. The complex
was characterized in phantoms and imaged in physiologically
intact mice at 7 Tesla (T) using three-dimensional (3D) gradient
echo and spectroscopic imaging (MRSI) sequences to mea-
sure spatial distribution and signal frequency.
Results: The reporter protons reside 6.5 A˚ from the para-
magnetic center, resulting in fast T1 relaxation (T1¼8 ms) and
a large paramagnetic frequency shift exceeding 60ppm. Fast
relaxation allowed short scan repetition times with high excita-
tion flip angle, resulting in high sensitivity. The large dipolar
shift allowed direct frequency selective excitation and acquisi-
tion of the dysprosium(III) complex, independent of the tissue
water signal. The biokinetics of the complex were followed in
vivo with a temporal resolution of 62 s following a single, low-
dose intravenous injection. The lower concentration limit for
detection was 23mM. Through MRSI, the temperature
dependence of the paramagnetic shift (0.28ppm.K1) was
exploited to examine tissue temperature variation.
Conclusions: These data demonstrate a new MRI agent with
the potential for physiological monitoring by MRI. Magn Reson
Med 77:1307–1317, 2017. VC 2016 The Authors Magnetic Res-
onance in Medicine published by Wiley Periodicals, Inc. on
behalf of International Society for Magnetic Resonance in
Medicine. This is an open access article under the terms
of the Creative Commons Attribution License, which per-
mits use, distribution and reproduction in any medium, pro-
vided the original work is properly cited.
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shift; temperature mapping
INTRODUCTION
Contrast agents are routinely used to improve the diag-
nostic specificity of MRI. The most common agents use
chelated gadolinium in which the local dipolar field of
the Gd ion causes an increase in the longitudinal relaxa-
tion rate (R1) of water molecules within the local vicinity
(and can increase tissue R2 through local susceptibility
effects). The presence of the contrast agent is inferred
from the resulting intensity change on T1 or T

2 weighted
MRI, respectively. These contrast systems are entirely
passive, accumulating and being removed from tissues
by diffusive processes only. Regionally differing contrast
enhancement arises from local rates of delivery, accumu-
lation, and clearance (1). A new frontier for MRI contrast
agent design is to create functionalized probes that target
specific cellular or physiological properties of the dis-
ease under investigation. Agents that bind to a range of
targets, such as collagen in fibrotic scar tissue (2–4) or
the endothelial wall (5,6) have been developed. All of
these agents also rely on indirect detection via changes
in water relaxation rates (R1, R2, or R

2) through conven-
tional gadolinium chelates (1) or iron oxide systems (7),
rather than detecting the contrast molecule directly.
The presence of the lanthanide metal within a contrast
agent acts on nuclei in the local structure of the chelat-
ing molecule and can induce large paramagnetic shifts,
yielding distinct resonances that can be detected, offer-
ing the possibility of directly detecting the agents them-
selves. Several studies have examined this effect as a
mechanism for molecular imaging, typically using thu-
lium complexes (TmDOTA– or TmDOTMA–). In these
cases, proton groups within the DOTA or DOTMA struc-
tures are paramagnetically shifted by tens to hundreds of
parts per million from the water signal, and therefore lie
far beyond the biological proton resonant frequency
range. Frequency selective acquisition can then be used
to detect these signals independent of the main water
peak (8–11). The magnitude of the paramagnetic shift is
sensitive to physiological conditions including tempera-
ture (10–12) and pH (12,13), conveying functionality to
these molecules. Previous studies have demonstrated the
feasibility of in vitro (10,11) and in vivo (8–10,14–19)
molecular imaging of these agents, and highlighted the
challenge in obtaining sufficient sensitivity, with most
studies using high-dose intravenous injection (5–10
times the clinical contrast dose) and renal ligation to pre-
vent clearance of contrast from blood and sustain an arti-
ficially enhanced tissue and vascular concentration.
Certain studies have explored the use of different lan-
thanide metals (9,11), but have not sought to optimize
the chelator to both maximize reporter group structure
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and optimize relaxation properties, which are essential
factors in defining overall measurement sensitivity. We
have previously developed a small molecular weight 19F-
labelled lanthanide metal chelate, in which the structure
was manipulated such that the dipolar field of the metal
enhanced the longitudinal relaxation rate of the 19F
nuclei. Increasing R1 allowed rapid pulsing in the MR
experiment, lowering the detection threshold to
approximately 20mM of complex (20,21). Here, we
apply the same principles of lanthanide enhanced
relaxation and design a new chelate with two chemi-
cally equivalent proton reporter groups to provide
favorable operating conditions for high-sensitivity
molecular MRI, while retaining the extremely large
paramagnetic shift of the proton reporter group. The
detected MR signal from the reporter groups is outside
the biological proton resonant frequency range, allow-
ing three-dimensional (3D) imaging of the molecular
probe against zero background. As an exemplar of
using this type of agent as a physiological probe,
regional tissue temperature variation was determined
in vivo using MR spectroscopic imaging. To distin-
guish this direct detection approach from other indi-
rect MR detection methods of similar lanthanide
probes (eg, PARACEST) (22), we previously suggested
the term PARASHIFT agents when describing such
lanthanide MR contrast agents (23).
METHODS
This study was conducted in two parts. First, the PARA-
SHIFT agents were synthesized and NMR relaxation
properties measured to determine the structural charac-
teristics of the complex. Second, the relaxation data
were used to define the optimal scanning conditions,
and in vivo imaging, biodistribution analysis, and tissue
temperature mapping studies were undertaken in mice.
Synthesis and Characterization of PARASHIFT Agents
A cyclen-based dysprosium(III) complex ([Dy.L1]) and
its gadolinium analog ([Gd.L1]) were designed by focus-
ing on a high number of reporter protons and their relax-
ation rates as the main design criteria. The complex
incorporates two tert-butyl (t-Bu) reporter groups, giving
FIG. 1. Synthesis scheme for the [Ln.L1] complexes, in which Ln was either Gd or Dy.
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18 equivalent protons whose resonance signal was to be
detected directly. The synthesis and characterization of
[Dy.L1] and [Gd.L1] were undertaken using established
methodology (Fig. 1/Supporting Information), as described
in recent work (23,24). The longitudinal relaxation rate
of the reporter group depends on the nature of the local
field experienced by those protons and varies with lan-
thanide ion, whereas the presence of a nonspherical
electronic distribution produces the dipolar paramag-
netic shift, with a magnitude dependent on the distance
and angle of the reporting nuclei to the paramagnetic
center. Our criteria were that R1 must be high to allow
fast pulsing, and the paramagnetic shift must be suffi-
cient to allow the shifted reporter resonance to be
excited and detected separately to the tissue signals from
water and fat. The shift must therefore be greater than
the imaging readout bandwidth, so that there is no con-
tamination of the PARASHIFT image by residual water
or fat signal. Based on previous work, Dy was found to
have more favorable relaxation properties than Tm, Tb,
or Ho (23,24); therefore, [Dy.L1] was chosen for PARA-
SHIFT imaging, whereas [Gd.L1] was synthesized for
standard MR contrast imaging.
High-resolution NMR field-dependent R1 measure-
ments were made, examining the tert-butyl resonance.
The nuclear relaxation times of the tert-butyl group of
[Dy.L1] were measured at six field strengths (4.7, 9.4,
11.7, 14.1, and 16.5 Tesla (T)) at 295 K using the
inversion-recovery technique (see Supporting Informa-
tion). The nuclear relaxation data were fitted by using a
modified MATLAB algorithm (The MathWorks, Natick,
Massachusetts) originally written by Dr. Ilya Kuprov
(Southampton University). The algorithm uses the
Solomon-Morgan-Bloembergen equation (Eq. [1]) to fit
the measured relaxation data using Levenberg-Marquardt
minimization of the nonlinear squares error function,
from which the electron-nuclear distance r was
estimated:
R1 ¼ 2
15
m0
4p
 2 g2N g2Ln m2B JðJ þ 1Þ
r6
3T1e
1 þ v2NT21e
þ 7T1e
1 þ v2eT21e
 
þ 2
5
m0
4p
 2 v2N m4eff
ð3kBTÞ2 r6
3tr
1 þ v2Nt2r
 
[1]
where m0 is the vacuum permeability, gN is the nuclear
gyromagneitc ratio, gLn is the Lande factor of the Ln ion,
mB is the Bohr magneton, tr is the rotational correlation
time, vN is the nuclear Larmor frequency, ve is the elec-
tron Larmor frequency, and meff is the effective magnetic
moment. The results were analyzed iteratively assuming
that longitudinal and transverse electronic relaxation
times (T1e and T2e) were of similar magnitude.
MRI Studies—General Details
In vivo imaging was performed using a 7T preclinical
MRI system (20-cm bore, Varian Direct Drive scanner,
Agilent, Palo Alta, California) equipped with a 39-mm
i.d. quadrature birdcage RF coil (Rapid Biomedical
GmbH, Germany) for excitation and detection of the
water and PARASHIFT agent signals. Mice were
mounted in a dedicated bed, which included a pneu-
matic pillow system to measure the gate acquisition to
animal respiration and a fiber-optic thermometry system
for temperature monitoring and control using a warm air
system (SA Instruments, Stony Brook, New York). Mice
were anaesthetized using isoflurane, and an intravenous
line was inserted into a tail vein to allow injection of
contrast agent from outside of the magnet. No other sur-
gical preparation was used. To confirm positioning and
visualize regional anatomy, conventional spin-echo MRI
scans were collected on the water resonance (pulse repe-
tition time (TR)/echo time (TE)¼ 2200 (gated)/10.93 ms,
451 mm thick slices, field of view (FOV) 35 35mm,
matrix 256 256). All animal experiments were per-
formed in compliance with the UK Government Home
Office under the Animals (Scientific Procedure) Act
1986.
Gd Uptake and Biodistribution Study
Biodistribution of the complexes was first studied using
the Gd analog in four HCT116 tumor-bearing CD1 Nu/Nu
Nude mice (Charles River, UK), although the analysis
only focused on normal tissues. Tissue uptake and clear-
ance of the complex was examined by dynamic contrast
enhanced (DCE) MRI using [Gd.L1], providing T1w con-
trast on conventional MRI. Slices were chosen through
the liver and kidneys. Gradient echo scans were acquired
every 6 s for 60 min, commencing five images before
administration of the contrast agent (dose of 0.1 mmol/kg
[Gd.L1], in a volume of 200ml given over 6 s). MRI
parameters were TR/TE¼ 23.45/4.40 ms; flip angle 30,
2-mm slice thickness, FOV 40 40 mm, matrix
256 256. DCE images were analyzed using ImageJ soft-
ware (http://imagej.nih.gov/ij/) to extract image intensity
changes over time. Regions of interest (ROI) were drawn
on liver, kidney, muscle and bladder, and mean ROI
intensity measurements were calculated for each time
point. Data were normalized to the mean background
level before contrast injection.
Following MRI, mice were sacrificed by cervical dislo-
cation and tissues excised immediately and freeze-
clamped in liquid nitrogen. To obtain tissue concentra-
tions over time, a further series of animals (n¼ 3 per
time point) were injected with [Gd.L1] and sacrificed at
10, 20, 40, and 80 min post injection. In all cases, three
separate tissue samples were taken from the kidney and
liver and stored at 80C before the analysis. Plasma
samples were taken at each time point and frozen. Sam-
ples were analyzed for Gd content using ICP-mass spec-
trometry (see Supporting Information).
PARASHIFT Dynamic Imaging Studies
PARASHIFT studies using the [Dy.L1] were performed
in CD1 wild type mice (Charles River, UK) without any
implanted tumor (n¼6). Unlike previous in vivo studies
using intravenous injection of paramagnetically shifted
agents (8,9,14–18,25), our animals were physiologically
intact, without renal ligation. Animals were positioned
in the birdcage coil and a 20-mm long, 5-mm diameter
NMR tube phantom containing 100mL of 6-mM solu-
tion of PARASHIFT agent positioned under the body of
the animal to allow for system calibration (scanner
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frequency) and to act as an external reference for quanti-
tation. This phantom was fastened to a line that allowed
it to be withdrawn from the imaging FOV following cali-
bration to avoid contamination of the in vivo signal from
the phantom. Measurements were made in three groups
of animals using three different methods to illustrate dif-
ferent aspects of the PARASHIFT molecular signal.
Measurement 1—Optimized Imaging of Regional Contrast
Distribution
For simple detection of the agent in vivo, an optimized
3D gradient-echo (3DGE) sequence was employed. Our
previous work has shown that once an imaging spectral
width (SW) is defined (which, with the choice of imag-
ing matrix size determines the minimum TE), the scan
should be collected at the shortest available TR under
Ernst angle conditions (21). The minimum allowed SW
for these experiments is defined by the fat-PARASHIFT
frequency difference. At the 7T operating frequency of
300 MHz, this frequency difference (1.5–61 ppm) corre-
sponds to 20 kHz. By restricting the imaging band-
width to 20 kHz and applying a sharp digital filter to the
data, images of the water or PARASHIFT peak were col-
lected simply by shifting the excitation and acquisition
center frequency of the scan. Signal excitation used a
nonspatially selective 1-ms-duration Gaussian excitation
pulse with a FWHM bandwidth of 2100 Hz, falling to a
fractional excitation of <103 at 20 kHz, which com-
pletely eliminated any observable contaminating signal
from one resonance while imaging the other. Scan
parameters were as follows: TE/TR¼1.45/2.87 ms
(ungated), 20-kHz spectral width, axial FOV 6464 mm,
matrix 32 32, 16 encodes in the third direction cover-
ing a slab thickness of 240 mm, yielding 15-mm thick sli-
ces. Scans used 42 signal averages for a total duration of
61.7 s per data set. Pulse flip angle was calibrated to the
Ernst angle of 46, which is possible for these experi-
ments because the PARASHIFT R1 is known and fixed
by the intramolecular interaction with the Ln ion, inde-
pendent of tissue concentration. Dual detection of nono-
verlapping water and PARASHIFT images were also
collected using signal excitation at the PARASHIFT fre-
quency with double receiver bandwidth of 40 kHz cen-
tered between the water and PARASHIFT frequencies
and double the number of readout matrix points.
The radiofrequency (RF) excitation power was cali-
brated on the water signal, and then the system was
retuned to the PARASHIFT frequency using the phantom
signal. Imaging FOV was positioned based on standard
proton MRI and the 3DGE sequence collected. This scan
provided intensity reference data for the PARASHIFT
phantom from which in vivo studies were quantified.
The phantom was then withdrawn from the FOV and a
repeat 3DGE sequence was collected to ensure that the
image matrix was free of any signal from tissue water.
Dynamic time series of 3DGE scans were then collected,
commencing with the injection of 200ml of PARASHIFT
agent (0.04 mmol/kg [Dy.L1]), followed by saline
flush and continuing for 30 min. Following PARASHIFT
imaging, the system was retuned to the water frequency
and a high-quality conventional MRI scan was collected
as an anatomical reference image using a standard multi-
slice SE sequence (respiratory gated TR/TE¼ 2200/10.9
ms, 50 1 mm thick slices, FOV 3535 mm, matrix
256 256).
PARASHIFT images were analyzed using ImageJ soft-
ware to extract image intensity changes over time. ROIs
were drawn on tissues of interest (liver, kidney, and
bladder), and mean ROI intensity values were extracted
for each time point. The preinjection data set containing
the PARASHIFT-filled phantom was used as the concen-
tration standardization reference level. The mean signal
from pixels placed centrally within the phantom (com-
pletely filled with solution) was determined and PARA-
SHIFT tissue concentration curves were calculated as the
ratio of the ROI mean signal relative to the phantom,
scaled by phantom concentration (6 mM). A ROI placed
outside the animal was used to measure the background
noise floor in the scans, to estimate the detection limit of
the contrast agent.
Measurement 2—Spectroscopic Imaging
To demonstrate detection of the signal spectroscopically
rather than by imaging, two-dimensional (2D) and 3D
spectroscopic imaging sequences were used. Sequence
parameters for 2DSI were TR/TE¼4.46/0.70 ms, FOV
6464 mm, matrix 16 16, spectral sweep width 20
kHz, 64 data points. Scans used 53 signal averages with
a scan duration of 61 s. The resulting data was three-
dimensional (two spatial, one spectroscopic) with the
spatial dimension localizing a thick axial (XY) plane,
condensing all detail along the z-direction of the magnet.
Sequence parameters for 3DSI were TR/TE¼ 7.69/0.73
ms, FOV 323264 mm, matrix 16 168, resulting in
8-mm thick axial slices. Spectral sweep width was 20
kHz with 128 data points. Scans used four signal aver-
ages with a scan duration of 63 s. For the 3D sequence,
the resulting data was four-dimensional (three spatial,
one spectroscopic). In both cases, the signal excitation
once again used the 1-ms nonselective Gaussian pulse as
in the 3DGE imaging studies.
Measurement 3—Temperature Mapping Studies
The chemical shift of the PARASHIFT signal is sensitive
to sample temperature, and can therefore be used for
temperature mapping. To determine the temperature
coefficient, in vitro measurements of the frequency shift
against temperature were made for the [Dy.L1] complex
in both deuterated water and rat plasma using standard
temperature controlled high-resolution NMR over the
range 298–318 K, spanning room to body temperature.
As pH can influence chemical shift, measurements were
also made while varying the pH between 4.6 and 7.6.
In vitro temperature mapping studies were made using
a sample of [Dy.L1] in a 5-mm NMR tube, which was
warmed in a water bath to 40C and then placed in a
polystyrene thermal insulating sleeve and imaged every
60 s as it cooled to room temperature. Sample tempera-
ture was monitored with the in vivo thermometry sys-
tem. Measurements were made using a 2DSI sequence
with TR/TE¼ 27.05/0.7 ms, spectral width 20 kHz, 512
sample points, 90 Gaussian excitation, FOV 3232 mm,
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matrix 32 32, and a single average for an acquisition
time of 27 s. The 2DSI data were processed using 3D
Fourier transformation, including 75-Hz exponential
line-broadening in the spectral domain. The frequency of
the major PARASHIFT line was determined at each tem-
perature by peak peaking (the presence of the smaller
second isomer resonance does not confound this spectro-
scopic measurement). To ensure frequency shifts were
only caused by temperature and not by differences in
local Bo field strength, a separate reference scan was col-
lected at the water frequency. Data were also presented
as images displaying signal intensity at a specific spec-
tral frequency.
In vivo temperature mapping studies were performed
in CD1 mice using the same experimental protocol as the
imaging experiments, but with the spectroscopic imaging
sequence. The in vivo measurements used a 3DSI
sequence with TR/TE¼ 7.69/0.70 ms, spectral width 20
kHz, 128 sample points, 90 Gaussian excitation, FOV
3232 64 mm, matrix 16 16 8, and four averages
for a total acquisition time of 63 s per data set. Measure-
ments were made preinjection and at 1, 2, 3, 4, 5, and
25 min post injection. The 3D spectroscopic imaging
data were processed using four-dimensional Fourier
transformation, including 75-Hz exponential line-
broadening in the spectral domain. Maps of local tissue
concentration of agent were created by integration of
peak area for every pixel in the 3D spatial volume.
Regional temperature differences were determined from
peak frequency changes.
RESULTS
The structure of the [Ln.L1] complex is shown in Figure
2a. The proton spectrum of [Dy.L1] (Fig. 2b) shows the
t-Bu PARASHIFT signal at 60.1 ppm (295 K, a fre-
quency shift of 20,000 Hz relative to water at 7 T) and a
smaller peak (12%) at 63.8 ppm. These peaks arise
from two isomers that are in slow chemical exchange.
The smaller peak is believed to be a stereoisomer with P
FIG. 2. Structure and properties of the PARASHIFT complex. (a) Structure of [Ln.L1]. (b) Proton spectrum collected on a 7T preclinical
imaging scanner from the tert-butyl signal region (centered at 60.1ppm) for [Dy.L1]. The signal was measured from 100mL of 6mM
solution using a volume imaging coil, with a 1-ms-long Gaussian 90 excitation pulse, 20-kHz spectral width, TR¼55 ms, 32 averages,
and a total acquisition time of 1.76 s. The long RF pulse was used to narrow the bandwidth and prevented excitation of water, but led
to a first-order phase difference between the major and minor resonances. The major resonance at 60.1ppm yields 88% of the signal,
with the minor resonance at 63.8ppm the remaining 12% signal. (c) Longitudinal relaxation rates for [Dy.L1] as a function of magnetic
field, (D2O 295 K) showing the fit (line) of the Solomon-Morgan-Bloembergen equation to the data (fixed r¼6.5 A˚; sr¼334 ps; T1E¼0.41
ps; leff¼10.6 B.M.). (d) Axial images from a 3DGE acquisition in a concentric tube phantom containing 3mM [Dy.L1] solution in the
central tube and water only in the outer tube. Upper row of the panel shows the water (left) and [Dy.L1] (right) images using frequency-
selective excitation of each resonance. Lower row of panel shows dual imaging acquisition using double bandwidth readout and Gaus-
sian signal excitation optimized at the [Dy.L1] frequency. Residual flip angle at the water frequency (20-KHz offset) yields the water
image.
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centers of the same configuration (SSS) and helicity
Lambda, whereas the major isomer is SSS-Delta. Each tBu
resonance relaxes at the same rate, consistent with this
assignment. Related triphosphinate lanthanide(III) com-
plexes have previously been examined, and assignments
are consistent with that work (26). Signals from the PMe
groups are not seen in this spectral region, as they reso-
nate at þ52,þ90, and þ99 ppm, between 110 and
160 ppm away from the t-Bu resonances. The t-Bu group
to metal ion distance was estimated at 6.5 (60.1)A˚, fol-
lowing previous density functional theory calculations of
similar structures (24). This estimate is supported by the
excellent fit between the NMR field-dependent R1 meas-
urements of the tert-butyl group and Bloch-Redfield-
Wangsness theory (23,24) using a distance of 6.5A˚ (Fig.
2c). It is important to stress that the spectral peak arises
directly from the tert-butyl protons, and that the R1 relax-
ation rate is independent of injected concentration—a
fundamental distinction from conventional MR agents, in
which the water relaxation rate varies proportionally with
instantaneous contrast agent concentration in the tissue.
Relaxation rate R1 was measured at 7 T to be 128 s
1,
with R2 of 227 s
1 (R1/R2¼ 0.56). Figure 2d shows
phantom images illustrating the 3DGE images from the
individual water or PARASHIFT resonances, and using
simultaneous dual PARASHIFT-water acquisition.
The biokinetics study of the complex using [Gd.L1]
and DCE-MRI (conventional, indirect T1 contrast) is
illustrated in Figure 3. DCE-MRI data demonstrated a
biphasic kinetic profile in the kidney with an early peak
2 min, arising primarily from the intravascular signal of
the injected agent (Fig. 3a), followed by a second broader
peak, as the complex exchanged in and out of body tis-
sues and was cleared through the kidneys. In muscle,
the tissue contrast peaked at 5 min and then decayed
away over the ensuing 40 min, with the [Gd.L1] com-
plex becoming visible in the bladder and continually
increasing over the following 45 min (data not shown).
Tissue Gd concentration was separately analyzed by
inductively coupled plasma mass spectroscopy of
excised tissue, and strongly paralleled the MRI data, as
expected (Fig. 3).
Figure 4 illustrates the PARASHIFT molecular MRI
measurements (direct detection of the tert-butyl group of
the [Dy.L1] complex). Passage of the agent through the
tissue could be followed by 3D imaging (Fig. 4), and ROI
analysis demonstrated similar biokinetics to the Gd ana-
log (Fig. 5). Mean peak SNR was 14.8 (range 8.9 to 22.1)
in kidney, 7.2 (range 4.0 to 10.0) in liver, and 30.0 (range
12.7 to 45.5) in bladder. Because the signal in the PARA-
SHIFT images arises from the molecule itself and the R1
relaxation rate is intrinsic to the intramolecular
FIG. 3. Biodynamics of [Gd.L1] in vivo. (a) MRI signal intensity curves obtained from selected ROIs using a DCE-MRI sequence. (b)
Measurements of tissue Gd concentration based on invasive tissue sampling. The kidney data (yellow) are shown overlaid onto the
DCE-MRI signal curve (a, left) to illustrate the similarity in time course (despite being in different animals).
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interaction, the signal was quantified against the external
reference solution acquired under the same conditions.
Peak concentration of PARASHIFT measured in the kid-
ney and liver ROIs was determined to be 200690 and
90620mmol dm3, respectively. Under these conditions,
the detection limit, as determined by the noise floor in
the scans, was estimated to be 23mmol dm3.
The relationship between PARASHIFT frequency and
sample temperature was determined in vitro to be linear
over the range 298–318 K (Supp. Figs. S1–S3 and Fig. 6)
with a temperature coefficient of 0.256 0.03 ppm/K in
D2O and 0.2860.01 ppm/K in mouse plasma. At the 7T
field used for imaging, this corresponds to 84 Hz/K,
which is small enough not to cause spatial distortion in
the image formation process (image bandwidth 312.5 Hz
per pixel), but is sufficiently large to allow accurate mea-
surement by optimized MRSI. Temperature mapping
data from the in vitro study is illustrated in Figure 6,
which shows spectroscopic images reconstructed across
the linewidth of the main PARASHIFT peak. Signal from
FIG. 4. PARASHIFT measurements in vivo. PARASHIFT signal from [Dy.L1] (color scale) overlaid onto conventional structural MRI scans.
Each column represents a different time point post injection. Within each column the data represent different spatial axial slices through
the mouse. Mean peak ROI signal to noise ratio in this animal was 9.9 in liver, 11.7 in kidney, and 18.6 in bladder.
FIG. 5. Time series analysis of PARASHIFT concentration from
selected ROIs in six mice.
PARASHIFT Imaging for Molecular MRI 1313
the minor isomer is seen to the right and shifts in paral-
lel with the major isomer. Measurement of chemical shift
as a function of pH revealed that frequency was
unchanged between pH of 4.6 and 7.0 and then changed
by 0.1 ppm at pH 7.6. Spectroscopic imaging allowed the
PARASHIFT peak frequency to be measured in vivo and
converted to tissue temperature (Fig. 7) based on the
measured temperature coefficient. Although the animal’s
core body temperature was maintained at 37C, the shift-
mapping studies demonstrated temperature variations
between tissues over time, which decreased by 348 Hz
(4.1 K) between initial detection of the intravascular sig-
nal and arriving in the bladder.
DISCUSSION
MRI is an inherently insensitive detection method, and
the ability to obtain direct molecular images by MRI
under thermal equilibrium magnetization conditions is
limited to compounds with tissue concentrations typi-
cally in the low millimolar range. Approaches to
enhance the sensitivity to molecular targets have used
conjugation of the target molecule to large reporter com-
pounds such as iron oxide particles, which yield con-
trast via indirect (and often diffuse) through-space
interactions, or other intermolecular interactions via
chemical exchange, such as in CEST and PARACEST
(22) methods. The use of paramagnetically shifted
resonances arising from nuclei within the structure of
the target molecule (8,9,15,17–19,23) offers an alternative
method based on small molecule structures, but optimi-
zation of the chelator structure to maximize imaging sen-
sitivity has seen little systematic investigation.
Relaxation rates are a key factor in defining detection
sensitivity. By manipulating the intramolecular distances
from the lanthanide ion to the reporter group, the R1
relaxation rate can be increased, allowing the MR
sequence to be run rapidly and with high flip angle,
maximizing the signal collection per unit time (21). R1
for the [Dy.L1]
 probe was 128s1 at 7 T, rising to 160
s1 at 9.4 T and 185 s1 at 11.7 T, which is slightly lower
than the relaxation rate of the H-3 protons in
[TmDOTMA] (reported to be 188 s1 at 9.4 T (9) and 211
s1 at 11.7 T) (16) and substantially lower than for the H-
6 protons of TmDOTP (reported as 625 s1 at 11.7 T)
(16). Although this might suggest TmDOTP has preferred
properties, sensitivity is not solely defined by R1, but
also by transverse signal decay (R2), which reduces the
overall signal. The very high reported R2 for TmDOTP at
11.7 T (1369 s1) (16) indicates that transverse signal loss
is significant for imaging, and linewidths are extremely
broad for spectroscopic detection. R1/R2 for TmDOTMA
are reported as 0.883 at 11.7 T (16) and 0.774 at 9.4 T (9).
However, excretion is very fast and the structure
presents no opportunity for structural modification, as
the equivalence of the 4 Me groups or 4 H on the ring is
lost by anything other than C-4 symmetric tetra-
substitution.
Choice of the lanthanide metal is fundamental to the
magnitude of the paramagnetic shift, as has been illus-
trated here for dysprosium (60-ppm shift) and gadolin-
ium (no shift). Selection of other lanthanide ions, such
as Tb, Tm or Er, provide agents with different properties
both in terms of reporter group relaxation rates and para-
magnetic shift. The more commonly studied thulium
complexes show paramagnetic shifts from 140 ppm (11)
to> 200 ppm (9), whereas characterization of similar Ln
structures to that used here shows that shifts ranging
from approximately 80 toþ 70 ppm are achievable (24).
Our recent work suggests that these shifts are not
entirely predicted by current theory (27), but the experi-
mentally demonstrated shifts offer opportunities for
more advanced imaging approaches.
Previous work observing paramagnetically shifted
ligand resonances has been limited by the need for large
doses, almost always requiring the use of renally ligated
animals to eliminate clearance of the agent, or the use of
continuous infusion to maintain sufficient signal inten-
sity. For example, the use of the rapidly cleared com-
plexes, [Tm.DOTP]5- or [Tm.DOTMA], has been
examined (8,14), in which the temperature and pH
dependence of a shifted resonance was monitored by
spectral imaging in rats undergoing continuous infusion
to maintain a complex concentration in the blood of the
order of 2–3 mmol/kg. In the current work we success-
fully imaged the dynamics of the complex using a single
intravenous injection in an intact animal at a dose of
0.04 mmol/kg of [Dy.L1]. Previous studies have also
achieved high spatial resolution of 1-ml voxels (14), but
FIG. 6. In vitro PARASHIFT temperature mapping studies. Each
image row presents data collected using a 2D spectroscopic
imaging acquisition at the specified sample temperature. Chemical
shift separation between each image is 0.52ppm. The spectral
data were reconstructed as images of PARASHIFT peak intensity
at each spectral frequency, and dependence of shift on tempera-
ture is plotted. The upper image rows (T¼307 K and 312 K) span
both the major and minor isomers and demonstrate that these
peaks shift in parallel; therefore, the presence of the minor isomer
does not confound temperature measurement using the major
isomer.
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again this has only been possible using high adminis-
tered doses in combination with small surface coils,
leading to restricted FOV. In studying dynamics, our
focus was on temporal rather than spatial resolution;
therefore, we selected a lower spatial resolution. How-
ever, taking into account differences in Bo field strength,
scan duration, total complex administered, and the sen-
sitivity differences between surface coils and our volume
coil (28), we calculate that our data show a sensitivity
improvement of a factor of 5 over this high resolution
study (14), and factors of 20 (18) and 60 (9,16,17) against
other recent studies using [TmDOTMA]. These numbers
are conservative estimates, as they make no allowance
for our use of a single intravenous injection. More
recently, [Tm.DOTMA] has been used in cell-labelling
studies in vivo, in which the complex was internalized
inside the cell population before injection (19), which
highlights an area for further evaluation of our complex.
We have demonstrated the ability to measure our agent
in vivo at a low tissue concentration of 23mmol dm3,
similar to the detection threshold for a fluorine-based
compound that we have previously reported (21). Fur-
ther increases in sensitivity require higher signal level
per molecule and slower clearance. Increasing the signal
is possible in imaging experiments through the use of
partial Fourier acquisition or ultrashort TE (UTE)
FIG. 7. In vivo PARASHIFT dual imaging experiment showing contrast agent distribution as a function of time and tissue temperature
assessment based on the frequency dependence of the PARASHIFT signal. Data were collected using a 3DSI sequence providing a
four-dimensional data set (three spatial and one spectral). The image panel presents the spectral grids for three of the MRSI slices
acquired 1min after intravenous injection (upper row), with the same data displayed as the reconstructed PARASHIFT tissue distribution
(derived from the peak area for each voxel in the 3DSI experiment) overlaid on the anatomical scans (middle row). The tissue concentra-
tion data at 25min post injection are shown in the bottom row. The anatomical scans were collected before contrast injection and show
the location of the PARASHIFT filled tube used for system calibration and as a concentration reference. This sample tube was with-
drawn remotely from the FOV before injection and therefore does not appear in the PARASHIFT images. PARASHIFT frequency is
temperature-dependent and can be used to map temperature differences. Spectra (lower right panel) were extracted from selected
regions of interest in kidney at the 1-min time point and from the bladder at the 25-min time point and corrected for differences in Bo
field strength in each region based on the water signal frequency. Significant changes in signal frequency (temperature) are apparent
over time between the kidney and bladder.
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imaging (19), to reduce signal loss from transverse relax-
ation. In theory, a factor of 1.3 is achievable from the
relaxation loss during the current 1.45-ms TE and the R2
of our molecule (227 s1). The rate of clearance and
excretion of the contrast agent is also relatively high.
Altering structure, such as conjugation of multiple cop-
ies to a larger molecule (29), can be used to change bio-
dynamics and further enhance detection sensitivity.
We have demonstrated temperature mapping using
this agent as a simple physiological probe, although we
acknowledge temperature can be measured using con-
ventional water MRI. Although the in vitro data demon-
strate the strong temperature dependence of the
chemical shift, other factors may affect the signal fre-
quency, including local Bo variation and tissue pH.
Because Bo inhomogeneity affects the PARASHIFT and
water signal frequencies equally, the in vivo PARA-
SHIFT data were corrected for inhomogeneity by refer-
encing the water frequency measured in each pixel using
the MRSI sequence tuned to the water resonance. Fur-
ther in vitro measurement demonstrated that shift was
essentially insensitive to pH. Therefore, while our data
would be strengthened by an independent in vivo tem-
perature reference, we conclude that the main source of
chemical shift variation is indeed temperature.
Future developments will modify the molecule to
place a substituent next to the t-butyl group whose shift
is sensitive to pH, creating a pH probe. Co-injection of
PARASHIFT agents with different functional properties
(eg, sensitivity to pH, T) and with different Ln ions
selected to produce opposing shifts into the upfield and
downfield regions of the spectrum, can then allow moni-
toring of multiple processes in vivo, simply by selection
of the appropriate bandwidth and resonant frequency. A
further possibility is to consider these types of structures
as “building blocks” for more complex forms. Alterna-
tively, linking structures based around only one species
of Ln metal but with different paramagnetic shifts engi-
neered via different Ln ion, reporter group distances
could produce multifunctional probes. An example
would be to create dual-probes with distinguishable sig-
nals that are physiologically sensitive and insensitive to
provide an internally referenced scan intensity. Dual or
multiprobe systems would also have the advantage that
biodynamics for each group would be guaranteed to be
identical.
An important alternate strategy for molecular MRI
employs chemical exchange effects (eg, chemical exchange
saturation transfer (CEST) imaging). This approach is again
an indirect detection method measuring changes in the
bulk (tissue) water signal as a result of saturation of a
frequency-shifted proton that is undergoing chemical
exchange between the molecular tracer of interest and the
bulk water. The frequency shift may be the result of natu-
ral chemical shift effects (30) or the result of induced shifts
from injected paramagnetic ions (PARACEST approaches
(22,31)). For PARACEST agents, the indirect nature of the
detection continues to be a challenge when determining
the absolute concentration for many cases of molecule.
Although a number of agents have been synthesized and
evaluated for sensitivity to physiological parameters in
vitro (reviewed in (32)), relatively few have been success-
fully demonstrated in vivo (33–39), and in some cases
have used direct injection into tissue of interest and/or
high injected doses to obtain high local tissue concentra-
tions. Recently, PARACEST agents have been used in
mouse models to measure extracellular pH (37–39) and
enzyme activity (36). In the context of the previous CEST-
based work, it is again important to stress that the PARA-
SHIFT approach we describe here is entirely distinct and
in no way relates to chemical exchange effects.
CONCLUSIONS
This study has demonstrated a new chelator structure for
high-sensitivity molecular imaging in vivo. This agent
can be detected using clinically relevant doses and used
to report simultaneously on tissue concentration and
physiological parameters, eg, tissue temperature.
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SUPPORTING INFORMATION
Additional Supporting Information may be found in the online version of
this article.
Fig. S1. PARASHIFT chemical shift as a function of sample temperature.
The chemical shift of the tert-butyl group in [DyL1]2 was measured as a
function of temperature in vitro, by high-resolution NMR at 11.7 T (1H, 500
MHz) both in D2O (blue) and murine plasma (red). Linear fitting revealed a
dependence of 0.31 ppm K21 in D2O, and 0.28 ppm K
21 in murine plasma,
in agreement with the phantom imaging study at 7 T in 0.9 w/v % NaCl
saline solution of 0.28 ppm K21.
Fig. S2. Chemical shift of the tert-butyl resonance versus 1/T2 for [Dy.L1]2
(11.7 T, 1H) by high-resolution NMR, over the temperature range 290–316
K.
Fig. S3. Longitudinal relaxation rate versus 1/T2 for [DyL1]2: the tert-butyl
resonance of approximately 260 ppm (11.7 T) was monitored by high-
resolution 1H NMR, over the temperature range 290–316 K.
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